BRASKEM SA
boothcheck covers BRASKEM SA (BAK) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed July 25, 2026.
• Braskem is the physical backbone of Brazilian plastics, running 28 industrial units across four petrochemical complexes that turn naphtha, ethane, refinery off gas and ethanol into ethylene and its derivatives, with polyethylene and polypropylene alone supplying 67% of revenue. • The balance sheet, not the plants, is the whole story: the company and certain subsidiaries filed for Precautionary Injunctive Relief in late June 2026, after which Fitch revised its rating to C and S&P to D [Source:
Is BAK overvalued? See what's priced in →
63 institutional managers reported holding BAK in 13F filings for the quarter ended 2026-03-31. Together they hold about 1% of the company; the top 10 hold 1%. 23 opened new positions that quarter. Held by Marshall Wace, Jane Street, Vanguard Group, among others. On the short side, 4.5M shares were sold short as of the 2026-06-15 count, about 0.6% of shares outstanding (1.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
It pays a dividend. Cash returned over the past three years: $2.55M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.